Cargando…
Engineered cells as glioblastoma therapeutics
In spite of significant recent advances in our understanding of the genetics and cell biology of glioblastoma, to date, this has not led to improved treatments for this cancer. In addition to small molecule, antibody, and engineered virus approaches, engineered cells are also being explored as gliob...
Autores principales: | Ramanathan, Aparna, Lorimer, Ian A. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850190/ https://www.ncbi.nlm.nih.gov/pubmed/33753869 http://dx.doi.org/10.1038/s41417-021-00320-w |
Ejemplares similares
-
Induction of senescence in primary glioblastoma cells by serum and TGFβ
por: Kumar, Ritesh, et al.
Publicado: (2017) -
Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma
por: Kalkan, Rasime
Publicado: (2015) -
Coordination of glioblastoma cell motility by PKCι
por: Baldwin, R Mitchell, et al.
Publicado: (2010) -
Glioblastoma Stem-Like Cells—Biology and Therapeutic Implications
por: Gürsel, Demirkan B., et al.
Publicado: (2011) -
Therapeutic Immunization against Glioblastoma
por: Schijns, Virgil E. J. C., et al.
Publicado: (2018)